Figure 4.

Frequency distribution of the type of systemic therapy in the last 2 weeks of life.

Six patients received two types of systemic therapy: one patient in 2015 (biological therapy + small-molecule targeted therapy), two patients in 2016 (chemotherapy + small-molecule targeted therapy and chemotherapy + immunotherapy), one patient in 2017 (chemotherapy + biological therapy) and two patients in 2019 (chemotherapy + small-molecule targeted therapy and small-molecule targeted therapy + biological therapy).